X-linked inhibitor of apoptosis protein (XIAP) predicts disease-free survival in BRAFV600E mutant papillary thyroid carcinoma in middle eastern patients

BACKGROUND: X-linked inhibitor of apoptosis (XIAP) is the most potent caspase inhibitory IAP family member and its over-expression is implicated in aggressive behavior of various solid tumors, including papillary thyroid carcinoma (PTC). BRAFV600E mutation is the most common oncogenic event in PTC a...

Descripción completa

Detalles Bibliográficos
Autores principales: Parvathareddy, Sandeep Kumar, Siraj, Abdul K., Bu, Rong, Iqbal, Kaleem, Al-Rasheed, Maha, Al-Haqawi, Wael, Annaiyappanaidu, Padmanaban, Siraj, Nabil, Ahmed, Saeeda O., Al-Sobhi, Saif S., Al-Dayel, Fouad, Al-Kuraya, Khawla S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790986/
https://www.ncbi.nlm.nih.gov/pubmed/36578953
http://dx.doi.org/10.3389/fendo.2022.1054882

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790986/
https://www.ncbi.nlm.nih.gov/pubmed/36578953
http://dx.doi.org/10.3389/fendo.2022.1054882

Ejemplares similares